James Mousseau

Company: Halda Therapeutics

Job title: Director - Chemistry

Seminars:

RIPTAC™ Therapeutics: A Modality to Take Hold of Human Diseases – Pushing the Frontiers of Induced Proximity Drugs 2:30 pm

How to harness RIPTAC™ therapeutics as a novel drug modality that employs a hold and kill mechanism to selectively target tumors and induce cancer cell death How to optimize the design of bifunctional small molecules to drive the formation of protein-protein interactions for enhanced therapeutic efficacy How to expand beyond traditional precision oncology by leveraging…Read more

day: Day One

Panel Discussion: Forging Strategic Pharma & Biotech Collaborations to Accelerate Induced Proximity Success 3:30 pm

What are the key partnership models – licensing, co-development, strategic acquisitions – between big pharma and small biotechs for advancing induced proximity programs effectively? How can cost efficient collaborations with academia and CROs help inform start-ups on resource allocation to de-risk induced proximity platforms before major investments? How can pioneering biotechs strategically frame their programs…Read more

day: Day Two